Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Towa Pharmaceutical Co ( (JP:4553) ) has shared an update.
Towa Pharmaceutical Co., Ltd. has revised its financial forecasts for the fiscal year ending March 31, 2025, reflecting a slight decrease in net sales and operating profit but a significant increase in ordinary profit and profit attributable to owners of the parent. The adjustments are attributed to foreign exchange gains, valuation of derivatives, and effective tax incentives, which have positively impacted the company’s financial outlook.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd., headquartered in Kadoma, Osaka, is a company engaged in the pharmaceutical industry. It focuses on the development, production, and marketing of generic drugs, catering to a wide market that demands affordable medication options.
Average Trading Volume: 126,107
Technical Sentiment Signal: Hold
Current Market Cap: Yen129.8B
See more insights into 4553 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue